Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With Ai Powered Digital Pathology For Building The Lab Of The Future
Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With Ai Powered Digital Pathology For Building The Lab Of The Future
02/27/23, 2:03 PM
Location
Industry
medical
biotechnology
health care
health diagnostics
medical device
health diagnostics
machine learning
artificial intelligence
biotechnology
health care
software
Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the acquisition of Mountain View, CA-based Crosscope. Crosscope is a digital pathology company with a turnkey imaging solution providing best-in-class workflow tools and slide management along with artificial intelligence (AI) and machine learning (ML) technology to assist pathologists with better and faster decision-making.
Company Info
Location
Hawthorne, New York, United States
Company info
Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work. Clarapath is developing tools and workflow solutions to improve outcomes and reduce costs in clinical and non-clinical pathology. With the rising demand for sample reviews and the reliance on a dwindling labor pool, Clarapath's SectionStar provides automated sectioning for non-clinical and clinical pathology laboratories. SectionStar is the first, fully automated, all-in-one tissue sectioning and transfer system that will dramatically increase capacity, reliability, and consistency while minimizing the need for highly skilled labor. Clarapath is headquartered and runs its medical device development in Hawthorne, NY. It also has a CLIA-certified Clinical Research Organization (CRO) that serves clinical and research organizations by processing tissue, performing whole slide imaging, and providing automated image processing based in New York City at the New York Genome Center.